To decide on a course of treatment, patients need to be told the truth straight up
Mark Chataway
Advertisement
Mark Chataway is co-chairman of Baird's Communication Management Consultants. He can be reached at mark.chataway@bairdscmc.com
Articles by Mark Chataway
Advertisement
Latest Updated Articles
Safe and Effective, Really?Published: June 1st 2011 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
